Here we go again, another lecture from the self appointed OTC compliance expert.
“No interim filings are needed.”
Sure, but when a tiny company claims a major revenue generating partnership, that becomes material. Acting like DBMM is drowning in clients is fantasy.
“No one can disclose revenues.”
Nobody asked for customer names. Just one number to prove this deal is real. DBMM has avoided that for years, which is why people ask.
“Xamun announced it first.”
Yes, through a pay to publish PR service anyone can use. Not exactly the sign of a major, market moving partnership.
“OTC Markets equals SEC compliance.”
No. OTC Markets is not the SEC, and pretending they are the same thing is flat out wrong.
“Bashers have no credibility.”
So anyone asking for basic proof is automatically wrong.
The funniest part is you keep telling shareholders to do their own due diligence while constantly telling them exactly what to believe and what to ignore. That is not DD. That is steering.
A struggling microcap pushing a big partnership with no filings, no numbers, and a bargain PR release will naturally raise questions. That is not bashing, it is common sense.
Market Data 
Markets 
AI
